Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2005
09/27/2005US6949522 treating or preventing HIV infection, HBV infection or abnormal cellular proliferation by administering said compounds or the related beta -D and beta -L-2'-halo-4'-thionucleosides
09/27/2005US6949519 Macrolide solvates
09/27/2005US6949512 administering to patient effective amount of lipopolysaccharide binding protein to elevate serum concentration of lipopolysaccharide binding protein in patient to sufficiently high level to suppress lipopolysaccharide induced release of cytokine
09/27/2005US6949356 Methods for improving secondary metabolite production in fungi
09/27/2005US6949353 capable of acting as an guanylyltransferase and methyltransferase consisting of a polypeptide from the N-terminus of flavivirus genus RNA-dependent RNA polymerase
09/27/2005US6949246 Monoclonal/polyclonal antibodies for serodetection and treatment of mycobacterium infections
09/27/2005CA2414271C Sustained-release preparations of quinolone antibiotics and method for preparation thereof
09/27/2005CA2079814C Cationic lipids for intracellular delivery of biologically active molecules
09/23/2005CA2502169A1 Products and methods for treating vaginal infections
09/22/2005WO2005087813A1 Chimeric antigens comprising an fc-fragment for eliciting an immune response
09/22/2005WO2005087787A1 2-fluoro-6-o-substituted ketolide derivative
09/22/2005WO2005087729A1 5-hydroxyindole-3-carboxylates derivatives and their use
09/22/2005WO2005087244A1 Antimicrobial composition
09/22/2005WO2005087243A1 Active ingredient complex of seaweed plants, especially the zosteraceae family, method for the production thereof, and use of the same
09/22/2005WO2005087241A1 Infection-controlling agent for livestock, poultry or fish
09/22/2005WO2005046567A3 Synergistic formulation of antioxidants and antimycobacterial agents: a method of making the same
09/22/2005WO2005023184A3 Antibiotic product, use and formulation thereof
09/22/2005WO2005007069A3 Soft gel formulations for saquinavir
09/22/2005WO2005002576A8 Imidazole derivatives and their use as protein kinases inhibitors
09/22/2005WO2004096807A8 Hiv integrase inhibitors
09/22/2005US20050209462 Synthesis of benzimidate from benzoic acid
09/22/2005US20050209451 Crystalline form of cefdinir
09/22/2005US20050209446 Novel 15-membered cyclic azalide, novel 16-membered cyclic diazalide derivative, and process for producing these
09/22/2005US20050209343 Percutaneous absorption promoters and compositions for treating athlete's foot
09/22/2005US20050209339 treating chronic rhinosinusitis such as allergic fungal sinusitis comprising daily oral administration of a composition from more than 500 mg to about 800 mg, preferably about 625 mg or 725 mg terbinafine base equivalent as hydrochloride
09/22/2005US20050209338 Phenethanolamine derivatives for treatment of respiratory diseases
09/22/2005US20050209325 Novel interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators
09/22/2005US20050209316 Lactone formulations and method of use
09/22/2005US20050209276 Etherification, dehalogenation; filtration, crystallization; bactericides
09/22/2005US20050209268 Administering optionally hydrogenated 2-alkyl-1-(alkylsulfonylalkyl)imidazo[4,5-c]quinoline-4-amines to induce biosynthesis of cytokines such as IFN-alpha and/or TNF-alpha; treating viral diseases and neoplastic diseases
09/22/2005US20050209267 Thioether substituted imidazoquinolines
09/22/2005US20050209248 Plymorphic forms of phenyl oxazolidinone derivatives
09/22/2005US20050209240 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors
09/22/2005US20050209223 N-(p-(substituted 1,2,3-triazol-1-yl)phenyl) derivatives of cycloazaalkanes; particularly useful for treating methicillin-resistant Staphylococcus aureas infections
09/22/2005US20050209219 Using tricyclic or tetracyclic antidepressant amitryptiline, imipramine, desipramine or FGF as inhibitors of acid sphingomyelinase which liberates ceramide, for prophylaxis and/or treatment of infectious diseases ( AIDS, hepatitis A, tuberculosis, rubella, SSME, influenza, rhinoviral diseases, malaria)
09/22/2005US20050209216 Inhibit the synthesis of TNF-alpha (TNF=tumor necrosis factor); use treating diseases linked to immune and inflammatory disorders or as analgesics; e.g. 7-(2-(4-(3-Trifluoromethylphenyl)piperazin-1-yl)ethyl)quinoline
09/22/2005US20050209212 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid; carbapenems derivatives containing a carboxy substituted phenyl group; broad spectrum antibacterial activity; good stability; beta-lactamases inhibitors; improvement over imipenem
09/22/2005US20050209197 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
09/22/2005US20050209192 Autoimmune disorders; modulating protein kinase C activity
09/22/2005US20050209188 Methods using glycosaminoglycans for the treatment of nephropathy
09/22/2005US20050209161 Drugs for treatment of inflammation/blood brain barrier degradation;administering to a subject in need of such treatment, a pharmaceutically effective amount of a peptide antagonist of zonulin, wherein the peptide antagonist binds to a zonula occludens toxin receptor
09/22/2005US20050209132 Cross-linked glycopeptide-cephalosporin antibiotics
09/22/2005US20050208678 Using capillary electrophoresis and laser induced fluorescent detection to monitor protein complex formation between membrane glycoproteins and helical polypeptides
09/22/2005US20050208653 Pancreatic progenitor cell culture for use in prevention and treatment of infection, diabetes and liver disorders
09/22/2005US20050208619 29 human secreted proteins
09/22/2005US20050208525 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
09/22/2005US20050208479 Immunoglobulin for prevention of variola infection; immunotherapeutics
09/22/2005US20050208463 Method of screening drug
09/22/2005US20050208158 nutraceutic mixture comprising plant extract of steroid saponins and bio-active zinc, bio-active selenium; treating HIV, herpes virus; antiinflammatory agent treating veins, capillaries, kidneys, bladder, and prostate gland; increasing good cholesterol concentration; strengthening immune system
09/22/2005US20050208155 New DNA polymerase inhibitors, mikanolide and dihydromikanolide
09/22/2005US20050208154 Antidepressants for treating manic disorders, psychosis; comprising ethyl cellulose, talc, polyvinylpyrrolidone; time-release dosage form; once daily
09/22/2005US20050208138 Injection of a biocompatible polymer, polysaccharide or polyamino acid, a cross-linker, and therapeutic agent into tumor; hydrogel formed in the tumor retains the therapeutic agent; drug delivery method; sustained releasing the biodrug
09/22/2005US20050208135 Monocompartment osmotic controlled drug delivery system
09/22/2005US20050208129 Prolonged release bioadhesive therapeutic systems
09/22/2005US20050208079 Glucan-based vaccines
09/22/2005US20050208071 Expresses all structural proteins of a pestivirus (e.g., BVDV) except for a functional C protein; coding sequences for a signal sequence within the C protein essential for post translational processing are retained or replaced by a sequence for analogous signal sequences from another pestiviral species
09/22/2005US20050208069 Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
09/22/2005US20050208042 Inducing lack of responsiveness to an antigen in an individual having a transplanted organ, tissue, cell; administering an effective amount of a humanized antibody; one antigen binding region of nonhuman origin and a portion of an immunoglobulin heavy chain of human origin
09/22/2005US20050208016 derivatives effectively block the inflammatory effects of RANTES, and are useful for the treatment of asthma, allergic rhinitis, atopic dermatitis, atheroma/atherosclerosis, and rheumatoid arthritis, hiv
09/22/2005US20050207987 Mixture of tobramycin in carrier; aerosols; respiratory system disorders; drug delivery
09/22/2005DE102004012455A1 New active substance complex from the plants of family Zosteraceae useful e.g. as nutraceuticals, functional foods, and for the prophylaxis and treatment of bacterial and viral infections
09/22/2005CA2559560A1 Antiviral composition comprising p-menthane-3, 8-diol
09/22/2005CA2558976A1 Mvl, an antiviral protein from a cyanobacterium
09/22/2005CA2558771A1 Multiple promoter expression cassettes for simultaneous delivery of rnai agents
09/22/2005CA2557926A1 Hiv integrase inhibitors
09/22/2005CA2557307A1 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005CA2557247A1 Compounds as inhibitors of hepatitis c virus ns3 serine protease
09/21/2005EP1577388A1 Adiponectin promoter and use thereof
09/21/2005EP1577383A1 Novel adaptor protein binding to mammalian toll-like receptor 3 and gene thereof
09/21/2005EP1577299A1 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient
09/21/2005EP1576964A1 Protease inhibitor
09/21/2005EP1576954A1 Preferential inhibition of release of pro-inflammatory cytokines
09/21/2005EP1576168A2 Therapeutic polypeptides nucleic acids encoding same and methods of use
09/21/2005EP1576159A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
09/21/2005EP1576102A2 Amidases, nucleic acids encoding them and methods for making and using them
09/21/2005EP1576092A2 Compounds and methods
09/21/2005EP1576090A2 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences
09/21/2005EP1576088A2 Dominant negative proteins and methods thereof
09/21/2005EP1576086A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576003A1 Peptides for preventing, diagnosing and treating animal and/or human leptospirosis
09/21/2005EP1575970A2 10-substituted macrolide antibiotics
09/21/2005EP1575953A1 Anhydrous crystalline form of valacyclovir hydrochloride
09/21/2005EP1575951A1 Heterocyclic compounds, methods of making them and their use in therapy
09/21/2005EP1575945A1 Oxazolidinone derivatives as antibacterial
09/21/2005EP1575914A1 Aromatic derivatives as hiv aspartyl protease inhibitors
09/21/2005EP1575617A1 Use of topical pharmaceutical compositions comprising an active agent and permeation-enhancing base for the manufacture of a medicament to treat various forms of inflammatory dermatosis
09/21/2005EP1575613A1 Trivalent vaccine with maternal antibody transfer via the milk
09/21/2005EP1575612A1 Immunogenic composition
09/21/2005EP1575600A1 Active ingredient combinations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride and preparations comprising said active ingredient combinations
09/21/2005EP1575595A1 Use of a combination containing a non-nucleoside reverse transcriptase inhibitor (nnrti) with an inhibitor of cytochrome p450, such as protease inhibitors
09/21/2005EP1575583A1 Treatment of hiv infection through combined administration of tipranavir and capravirine
09/21/2005EP1575567A1 Method and reagents for treating or preventing atherosclerosis and diseases associated therewith
09/21/2005EP1575549A2 Identification of anti-hiv compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid
09/21/2005EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
09/21/2005EP1575493A2 Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives
09/21/2005EP1575486A2 Method and compositions for identifying anti-hiv therapeutic compounds
09/21/2005EP1575483A2 Attenuated gram negative bacteria
09/21/2005EP1542728A4 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same
09/21/2005EP1299382B1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
09/21/2005EP1278531B1 Use of a preparation for topically treating manifestations caused by virus infections
1 ... 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 ... 1798